Control of severe hyperparathyroidism and regression of a brown tumour after treatment with i.v. alfacalcidol in a uraemic patient.
Mourad
G
G
Department of Nephrology, University Hospital Lapeyronie, Montpellier, France.
Argilés
A
A
Vela
C
C
Lorho
R
R
Flavier
J L
JL
Canaud
B
B
Mion
C M
CM
D000368:Aged; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007262:Infusions, Intravenous; D008439:Maxillary Diseases / Q000188:drug therapy* / Q000209:etiology; D010002:Osteitis Fibrosa Cystica / Q000188:drug therapy* / Q000209:etiology; D014511:Uremia / Q000150:complications*
D006887:Hydroxycholecalciferols; C008088:alfacalcidol